Pfizer (PFE) Tops Q1 EPS by 15c, Raises FY Guidance

Pfizer (NYSE: PFE) reported Q1 EPS of $0.93, $0.15 better than the analyst estimate of $0.78. Revenue for the quarter came in at $14.6 billion versus the consensus estimate of $13.6 billion.

GUIDANCE:

Pfizer sees FY2021 EPS of $3.55-$3.65, versus the consensus of $3.36. Pfizer sees FY2021 revenue of $70.5-72.5 billion, versus the consensus of $62.99 billion.

For earnings history and earnings-related data on Pfizer (PFE) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Baidu slips as Q2 results miss estimates despite growth in AI cloud business